Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06280209
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-01-26
Brief Title:
A Phase 12 Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
Sponsor:
Organization:
BioMarin Pharmaceutical